Details of CPPsite entry with Sequence RRRRRR |
Primary information | |
---|---|
PEPTIDE SEQUENCE | RRRRRR |
CPPsite ID | 2532, 2533, 1032, |
PEPTIDE NAME | V2, V2R, R6 |
CHIRALITY | L, L, L |
LINEAR/CYCLIC | Linear, Linear, Linear |
SOURCE | Synthetic, Synthetic, Synthetic |
CATEGORY | Cationic, Cationic, Cationic |
SUB CELLULAR LOCALIZATION | Cytoplasm and Nucleus, NA, Cytoplasm and nucleus |
N-TERMINAL MODIFICATION | Conjugated to FITC modified folding domain via ?-alanine–glycine– glycine linker, Conjugated to FITC modified folding domain via ?-alanine–glycine– glycine linker, Conjugation with fluorescein with 6-aminohexanoic acid (Ahx) spacer |
C-TERMINAL MODIFICATION | Amidation, Amidation, Free |
CHEMICAL MODIFICATION | NA, NA, NA |
UPTAKE EFFICIENCY | V2 has a stronger preference to accumulate within the nuclear bodies that contain a high con- centration of DNA, Cells indicates a lack of cellular uptake of V2R, Medium (relative to Tat (49-57)) |
PROPOSED UPTAKE MECHANISM | NA, NA, Probably non-endocytic pathway |
INVITRO/INVIVO | In vitro, In vitro, In vitro |
CELL LINE | NIH-3T3 Swiss mice fibroblasts and Jurkat E6 cells, NIH-3T3 Swiss mice fibroblasts and Jurkat E6 cells, Jurkat |
In VIVO MODEL | NA, NA, NA |
CARGO | Peptide (FITC labelled peptide), Peptide (FITC labelled peptide), Fluorophore (fluorescein) |
PMID | 25524829, 25524829, 11087855 |
PATENT | Unknown, Unknown, US 6593292 |
Tertiary Structure (Technique) | 2532 (PEPstrMOD), 2533 (PEPstrMOD), 1032 (PEPstrMOD), |